1) Horii A, Uno A, Kitahara T, et al. : Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases. J Vestib Res 17: 1-8, 2007.
2) Horii A, Mitani K, Kitahara T, et al. : Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otol Neurotol 25: 536-543, 2004.
3) Hosaka T, Awazu H, Aoki T, et al. : Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale. Int J Psychiatry Clin Pract 3: 43-48, 1999.
4) Licata F, Li Volsi G, Maugeri G, et al. : Excitatory and inhibitory effects of 5-hydroxytryptamine on the firing rate of medial vestibular nucleus neurons in the rat. Neurosci Lett 154: 195-198, 1993.
5) Goto F, Tsutsumi T and Ogawa K : Successful treatment of relapsed Ménière’s disease using selective serotonin reuptake inhibitors: A report of three cases. Exp Ther Med 7: 488-490, 2014.